Brief: G1 Therapeutics Provides Initial Update On Phase 2 Bladder Cancer

G1 Therapeutics

04/01/2023 11:38

Jan 4 (Reuters) - G1 Therapeutics Inc  GTHX.O :
    * G1 THERAPEUTICS PROVIDES INITIAL UPDATE ON PHASE 2 BLADDER
CANCER TRIAL; PROGRESSION FREE SURVIVAL (PFS) DATA EXPECTED IN
MID-2023
    * G1 THERAPEUTICS - ADDITIONAL SAFETY AND EFFICACY DATA,
INCLUDING
PRIMARY ENDPOINT OF PROGRESSION FREE SURVIVAL (PFS), ARE
ANTICIPATED IN MIDDLE OF 2023
    * G1 THERAPEUTICS INC: INITIAL PHASE 2 RESULTS SHOW
CONFIRMED
OBJECTIVE RESPONSE RATE (ORR) PER RECIST V1.1 WAS COMPARABLE
BETWEEN ARMS

Source text for Eikon:  ID:nGNXbRjsns 
Further company coverage:  GTHX.O 
 ((Reuters.Briefs@thomsonreuters.com;))